1
|
Chiappini F: Circulating tumor cells
measurements in hepatocellular carcinoma. Int J Hepatol.
2012:6848022012. View Article : Google Scholar : PubMed/NCBI
|
2
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hiotis SP, Rahbari NN, Villanueva GA,
Klegar E, Luan W, Wang Q and Yee HT: Hepatitis B vs. hepatitis C
infection on viral hepatitis-associated hepatocellular carcinoma.
BMC Gastroenterol. 12:642012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Tang ZY: Hepatocellular carcinoma - cause,
treatment and metastasis. World J Gastroenterol. 7:445–454.
2001.PubMed/NCBI
|
5
|
Yao DF, Dong ZZ and Yao M: Specific
molecular markers in hepatocellular carcinoma. Hepatobiliary
Pancreat Dis Int. 6:241–247. 2007.PubMed/NCBI
|
6
|
Malaguarnera G, Giordano M, Paladina I,
Berretta M, Cappellani A and Malaguarnera M: Serum markers of
hepatocellular carcinoma. Dig Dis Sci. 55:2744–2755. 2010.
View Article : Google Scholar : PubMed/NCBI
|
7
|
El-Tayeh SF, Hussein TD, El-Houseini ME,
Amer MA, El-Sherbini M and Elshemey WM: Serological biomarkers of
hepatocellular carcinoma in Egyptian patients. Dis Markers.
32:255–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bertino G, Ardiri A, Malaguarnera M,
Malaguarnera G, Bertino N and Calvagno GS: Hepatocellualar
carcinoma serum markers. Semin Oncol. 39:410–433. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Yao DF, Dong ZZ, Yao DB, Wu XH, Wu W, Qiu
LW, Wang HM and Meng XY: Abnormal expression of hepatoma-derived
gamma-glutamyltransferase subtyping and its early alteration for
carcinogenesis of hepatocytes. Hepatobiliary Pancreat Dis Int.
3:564–570. 2004.PubMed/NCBI
|
10
|
Okuyama K: Separation and identification
of serum gamma-glutamyl transpeptidase isoenzymes by wheat germ
agglutinin affinity electrophoresis: a basic analysis and its
clinical application to various liver diseases. Keio J Med.
42:149–156. 1993.
|
11
|
Bellin M, Tumino E, Giordani R, Fabrini G,
Costa F, Galli R, et al: Serum gamma-glutamyl transpeptidase
isoforms in alcoholic liver disease. Alcohol Alcohol. 32:259–266.
1997. View Article : Google Scholar : PubMed/NCBI
|
12
|
Xu K, Meng XY, Wu JW, Shen B, Shi YC and
Wei Q: Diagnostic value of serum gamma-glutamyl transferase
isoenzyme for hepatocellular carcinoma: a 10-year study. Am J
Gastroenterol. 87:991–995. 1992.PubMed/NCBI
|
13
|
Xu KC, Meng XY, Shi YC, Ge ZJ, Ye L, Yu ZJ
and Yang DM: The diagnostic value of a hepatoma-specific band of
serum gamma-glutamyl transferase. Int J Cancer. 36:667–669. 1985.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Whitfield JB: Gamma glutamyl transferase.
Crit Rev Clin Lab Sci. 38:263–355. 2001. View Article : Google Scholar
|
15
|
Ikeda Y and Taniguchi N: Gene expression
of gamma-glutamyltranspeptidase. Methods Enzymol. 401:408–425.
2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kojima J, Kanatani M, Nakamura N,
Kashiwagi T, Tohjoh F and Akiyama M: Electrophoretic fractionation
of serum gamma-glutamyl transpeptidase in human hepatic cancer.
Clin Chim Acta. 106:165–172. 1980. View Article : Google Scholar : PubMed/NCBI
|
17
|
Sawabu N, Nakagen M, Ozaki K, Wakabayashi
T, Toya D, Hattori N and Ishii M: Clinical evaluation of specific
gamma-GTP isoenzyme in patients with hepatocellular carcinoma.
Cancer. 51:327–331. 1983. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kew MC, Wolf P, Whittaker D and Rowe P:
Tumour-associated isoenzymes of gamma-glutamyl transferase in the
serum of patients with hepatocellular carcinoma. Br J Cancer.
50:451–455. 1984. View Article : Google Scholar : PubMed/NCBI
|
19
|
Cui R, He J, Zhang F, Wang B, Ding H, Shen
H, Li Y and Chen X: Diagnostic value of protein induced by vitamin
K absence (PIVKAII) and hepatoma-specific band of serum
gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma
markers complementary to alpha-fetoprotein. Br J Cancer.
88:1878–1882. 2003. View Article : Google Scholar
|
20
|
Yao DF and Dong ZZ: Hepatoma-related
gamma-glutamyl transferase in laboratory or clinical diagnosis of
hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 6:9–11.
2007.PubMed/NCBI
|
21
|
Grizzi F, Franceschini B, Hamrick C,
Frezza EE, Cobos E and Chiriva-Internati M: Usefulness of
cancer-testis antigens as biomarkers for the diagnosis and
treatment of hepatocellular carcinoma. J Transl Med. 5:32007.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Tangkijvanich P, Tosukhowong P, Bunyongyod
P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P and Poovorawan Y:
Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in
Thailand. Southeast Asian J Trop Med Public Health. 30:110–114.
1999.PubMed/NCBI
|
23
|
el-Houseini ME, Mohammed MS, Elshemey WM,
Hussein TD, Desouky OS and Elsayed AA: Enhanced detection of
hepatocellular carcinoma. Cancer Control. 12:248–253.
2005.PubMed/NCBI
|
24
|
Wang JJ and Cao EH: Rapid kinetic rate
assay of the serum alpha-L-fucosidase in patients with
hepatocellular carcinoma by using a novel substrate. Clin Chim
Acta. 347:103–109. 2004. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zhou L, Liu J and Luo F: Serum tumor
markers for detection of hepatocellular carcinoma. World J
Gastroenterol. 12:1175–1181. 2006.PubMed/NCBI
|
26
|
Gomaa AI, Khan SA, Leen EL, Waked I and
Taylor-Robinson SD: Diagnosis of hepatocellular carcinoma. World J
Gastroenterol. 15:1301–1314. 2009. View Article : Google Scholar : PubMed/NCBI
|
27
|
Wright LM, Kreikemeier JT and Fimmel CJ: A
concise review of serum markers for hepatocellular cancer. Cancer
Detect Prev. 31:35–44. 2007. View Article : Google Scholar : PubMed/NCBI
|